The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable.

Forsythe, Steven; Cohen, Joshua; Neumann, Peter; Bertozzi, Stefano M; Kinghorn, Anthony

Forsythe, Steven; Cohen, Joshua; Neumann, Peter; Bertozzi, Stefano M; Kinghorn, Anthony.

Forsythe S; Avenir Health, Glastonbury, CT, USA. Electronic address: sforsythe@avenirhealth.org.
Cohen J; Joshua P. Cohen Healthcare Analytics, Boston, MA, USA.
Neumann P; Tufts Medical Center, Boston, MA, USA.
Bertozzi SM; University of California Berkeley School of Public Health, Berkeley, CA, USA; Instituto Nacional de Salud Pública, Cuernavaca, México; University of Washington, Seattle, WA, USA.
Kinghorn A; Perinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa.

Value Health ; 23(11): 1427-1431, 2020 11.

Article in English | MEDLINE | ID: covidwho-546815

Subject(s)

Coronavirus Infections; Coronavirus; Pandemics; Pneumonia, Viral; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Humans; Lopinavir; Public Health; Ritonavir; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Pandemics Limits: Humans Language: English Journal: Value Health Journal subject: Pharmacology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google